Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.
Saved in:
| Title: | Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling. |
|---|---|
| Authors: | Berwick, Daniel C.1,2, Javaheri, Behzad3, Wetzel, Andrea1, Hopkinson, Mark3, Nixon-Abell, Jonathon1, Grannò, Simone1, Pitsillides, Andrew A.3, Harvey, Kirsten1 kirsten.harvey@ucl.ac.uk |
| Source: | Molecular Neurodegeneration. 1/19/2017, Vol. 12, p1-17. 17p. 6 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 17501326 |
|---|---|
| DOI: | 10.1186/s13024-017-0153-4 |
